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Objective: To present the results of a series of laparoscopic middle pancreatectomies with roux-en-Y 
duct-to-mucosa pancreaticojejunostomy. 
Summary of Background Data: Middle pancreatectomy makes it possible to preserve pancreatic 
parenchyma in the resection of lesions that traditionally have been treated by distal splenopancrea-
tectomy or cephalic duodenopancreatectomy. The laparoscopic approach could minimize the 
invasiveness of the procedure and enhance the benefits of middle pancreatectomy. 
Methods: From March 2005 to October 2007, 9 consecutive patients with benign or low malignant 
potential lesions in the pancreatic neck or body underwent surgery. Laparoscopic middle pancre-
atectomy with a roux-en-Y duct-to-mucosa pancreaticojejunostomy was planned on all of them. In the 
first 2 patients, the pancreas was transected by endostapler; in the last 7, the staple line was reinforced 
with absorbable polymer membrane.  
Results: The intervention was concluded laparoscopically in every case except 1 (laparoscopic-
assisted) in which pancreaticojejunostomy was performed by means of minilaparotomy. Mortality was 
0% and perioperative morbidity was 33%, (fistula of the cephalic stump in the first 2 patients (22%)). 
The pancreaticojejunostomy fistula rate was 0%. The median postoperative hospital stay was 5 days 
(range, 3–41). In the last 7 patients, in which pancreas was transected with staple line reinforcement 
material there were no stump fistulas; morbidity decreased to 14% and the median hospital stay was 4 
days (range, 3–30). 
Conclusions: Laparoscopic middle pancreatectomy is feasible and safe. Duct-to-mucosa 
pancreaticojejunostomy can be performed safely using this approach. The method of pancreatic 
transection seems to be decisive in the incidence of cephalic stump fistulas. 
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 In the last decade, advances in pancreatic surgery have developed in 2 fundamental directions, 
both of which seek to minimize the aggressiveness of the procedures. On the one hand, techniques have 
been designed for partial pancreatic resection to preserve the spleen and as much pancreatic parenchyma 
as possible. The benefits of open middle pancreatectomy (MP) have been definitely stated in a recent 
revision1 and in 2 series based on 40 and 100 patients, respectively.2,3 On the other hand, laparoscopic 
approach, which has been slow to become generalized in the field of pancreatic surgery, is now in 
widespread use. The benefits of laparoscopy have been proven in different studies for distal 
pancreatectomies and enucleations.4–6 As a result of both of these technical advances, we can now offer 
laparoscopic middle pancreatectomy (LMP) to patients with benign or low malignant potential tumors in 
the pancreatic neck or body and near the main pancreatic duct. One single 6-case series about LMP has 
been published with pancreatogastrostomy (PG) reconstruction in all cases.7 We have found only 2 
references in the literature about LMP with roux-en-Y duct-to-mucosa pancreaticojejunostomy (PJ), being 
one of them is our first case included in the Spanish National Registry of Laparoscopic Pancreatic 
Surgery.8,9 The aim of this article was to describe our surgical technique for LMP with duct-to-mucosa PJ 
and report the results of our initial experience with 9 patients. 
 
METHODS 
Patients 
From March 2005 to November 2007, 9 patients with benign or low malignant potential tumors 
in the pancreatic neck or body underwent surgery at our center. Computed tomography (CT) or 
magnetic resonance imaging and endoscopic ultrasound guided fine-needle aspiration biopsy com-
plemented the ultrasound diagnosis. Mucinous cystic neoplasms and intraductal papillary mucinous 
neoplasms were managed according to the Sendai International Consensus Guidelines.10 The 
advantages, disadvantages, and possible risks of the surgical procedure were explained to the patient 
and informed consent was obtained. Data were collected prospectively. 
Surgical Technique 
The patient is placed in supine position with legs apart; the surgeon stands between the legs. 
Pneumoperitoneum is created (CO2 at 12 mm Hg) using an open technique to insert a Hasson  
 
  
periumbilical trocar. A 3-chip digital camera (TRICAM SLII 20221140; Karl Storz, Tuttlingen, Germany) 
is used with 30 degree optics. After general examination of the abdominal cavity, the other trocars are 
inserted: two 12-mm working trocars level with the right and left midclavicular line, about 2 cm above the 
umbilicus. The first assistant then inserts a 5-mm trocar at the left anterior axillary line, and the second 
assistant inserts an 11-mm trocar below the right edge of the ribs (Fig. 1). A window is opened trough the 
gastrocolonic ligament for visualization of the lesser sac, taking care not to damage the gastroepiploic 
arcade. The gastric body is cranially retracted to expose the anterior face of the pancreatic neck, body, and 
tail. Once the existence of other lesions is ruled out, the tumor is located using a laparoscopic ultrasound 
probe (Philips HDI 5000, Bothell, WA, 5–9 MHz Laparoscopic Transducer) to establish its relation to the 
main pancreatic duct. The ultrasound control helps to mark the proximal and distal resection lines with a 
safety margin of 1 cm. With a hook, the peritoneum is released from the lower edge of the pancreas, 
exposing the superior mesenteric vein. A tunnel is opened behind the neck of the pancreas by blunt 
dissection and a cotton tape is placed around the gland (Fig. 2A). By pulling this tape upward, the 
pancreatic neck is dissected proximally and distally about 2 cm, easing insertion of an endostapler to 
perform the proximal pancreatic transection. In the first 2 patients, we used an endostapler (EndoGIA II 
60-3.5, Auto Suture, Norwalk, CT) with 3.5-mm staples. In the last 7 patients, we used the same stapler 
but with 4.8-mm staples (EndoGIA II 60-4.8) and staple-line reinforcement (GORE SEAMGUARD 
Bioabsorbable Staple Line Reinforcement, W.L. Gore & Associates, Flagstaff, AZ) (Fig. 2B). In these 
cases, the trocar located in the left midclavicular line was replaced with a 15-mm trocar. To release the 
distal stump of the pancreas from the splenic artery and vein, small connecting vessels are sectioned 
between clips (Horizon, Endoscopic Ligating Clips, Weck; Teleflex, Limerick, PA) or with harmonic 
scalpel (Fig. 2C). This dissection is carried up to 2 cm far from the distal section line. Two sutures are 
placed on the upper and lower edges of the pancreatic section line. These stay sutures serves a hemostatic 
function and also they allow the pancreatic stump to be mobilized for pancreaticojejunostomy when 
pulled up properly by the first assistant. Next, the distal section of the specimen is performed with 
monopolar and harmonic scalpels, taking particular care to locate the Wirsung duct (Fig. 2D). Once the 
duct is identified, a 2-mm silastic tutor (06 French) is inserted. Pancreaticojejunal reconstruction is 
performed using a 50-cm retrocolic roux-en-Y jejunal loop. The anastomosis is a duct-to-mucosa 
pancreaticojejunostomy. A first line of sutures with 3/0 silk is placed with interrupted stitches between the 
antimesenteric edge of the jejunal serosa and the posterior side of the pancreatic capsule (Fig. 2E). After 
opening a small orifice in the seromuscular layer with the hook (Fig. 2F), the mucosa is everted to prepare 
for duct-to-mucosa anastomosis. It is performed by placing 4 cardinal stitches of absorbable monofila-
ment suture (Monocryl 6/0, C9260, Ethicon Products, Johnson & Johnson) between the everted mucosa 
and the main pancreatic duct (Fig. 2G). The last stitch secures the tutor before inserting it into the loop. 
This anastomosis is completed with another line of sutures between the anterior side of the pancreas and 
the jejunal serosa with interrupted sutures of 3/0 silk (Fig. 2H). Fibrin glue is placed around the 
pancreaticojejunostomy to protect the anastomosis. Finally, mechanical side-to-side jejunojejunostomy is 
performed with a stapler (EndoGIA II 60-2.5) and the mesenteric defect closed. The specimen is drawn 
into a bag (Endocatch, Auto Suture, Norwalk, CT) and removed through the umbilical incision, which 
does not have to be enlarged. 
In all cases, amoxicillin/clavulanic acid was given for antibiotic prophylaxis; somatostatin 
analog (100 µg/8h subcutaneously for 7 days) was administered in order to prevent pancreatic 
fistulas.11 Routine drainage was not used in any case, except for patient 3, after the experience of 
pancreatic fistula in the first 2 patients and for patient 9 in whom a partial gastrectomy was also 
performed. The nasogastric tube was removed at the end of the procedure and oral tolerance initiated 
on the first postoperative day. All patients were examined at the clinic after 1 and 6 months and then 
yearly. 
 
RESULTS 
The demographic and clinical characteristics of the patients are summarized in Table 1. Eight 
of the 9 patients were women. The mean age was 53 years (range, 28-60). In every case, the tumor was 
less than 3 mm from the duct, which contraindicated enucleation (Fig. 3). All the tumors were excised 
with both margins of at least 1 cm, as defined by intraoperative ultrasound study. 
We treated 5 cystic tumors. In 3 patients, in which focal intraductal papillary mucinous neoplasms 
(patient 5), and mucinous cystic neoplasms (patients 7 and 8) were suspected before surgery, the 
definitive histologic diagnosis was serous cystic neoplasm. 
 
Four neuroendocrine tumors were resected. All of them were small nonfunctioning 
neuroendocrine tumors and they were benign according to the definitive pathologic study: a 
fibrous connective tissue band surrounded tumors, mitotic rate was lower than 1 per 20 high power fields 
and no phenomena of vascular invasion were observed. 
The data on the surgical aspects and results are shown in Table 2. In every case, the procedure was 
completed using the laparoscopic technique, except in case 2 in which the Wirsung duct could not be 
identified. Supraumbilical minilaparotomy (8–9 cm) was performed to identify the duct and PJ was 
completed as described. In all cases, the splenic vessels, artery and vein, were preserved. In patients 3 
and 4, there was moderate inflammation distal to the tumor that made it difficult, but not impeded, to 
free the splenic vessels from the pancreatic body. These 2 patients required the longest operative times, 
exception made of the last case, in which a partial gastrectomy was performed due to a gastrointestinal 
stromal tumor. In every case, the pancreas under reconstruction had a normal duct (diameter 
approximately 2 mm) and its consistency was soft (except for patients 3 and 4). 
An associated procedure was performed in 6 patients (66%): 5 cholecystectomies due to 
cholelithiasis and a partial gastrectomy due to a 1.3-cm gastrointestinal stromal tumor located in the 
posterior face of the lesser gastric curve. The mean operative time was 435 minutes (range, 357-509 
minutes). 
Blood loss was less than 100 mL in all patients. Patient 2 developed hemorrhage due to arterial 
bleeding of the cephalic stump on the first postoperative night. She required emergency laparotomy 
and the administration of 5 units of blood and 4 units of plasma. 
Early surgical complications were observed in 3 patients. The first 2 patients of the series developed 
fistula of the cephalic stump and were treated satisfactorily by transgastric  drainage and endoscopic 
sphincterotomy; in them, pancreas had been transected by endostapler without staple-line rein-
forcement or selective duct suture. The third surgical complication was observed in patient 4, who was 
released 6 days after the procedure, but returned on day 10 with fever and leukocytosis. An ultrasound 
study and CT revealed the existence of an abscess in the resection bed. After 7 days of antibiotic 
treatment with slow improvement, it was treated with endoscopic ultrasound puncture evacuating 20 
mL of pus. No transgastric drain was left. Control US study was performed 4 days and 4 weeks after 
evacuation of this abscess and no residual collection was found. 
 
Only patient 2 presented medical complications, with atelectasis and left pleural effusion on the 
chest x-ray that responded adequately to routine treatment. 
At a median follow-up of 13 months (range, 2–34 months), all the patients are alive. We have not 
observed long-term complications other than a small umbilical hernia in patient 3 whose BMI was 35 
kg/m2, which was resolved surgically. 
Six patients (66%) had no incidents following the procedure. The median postoperative stay for this 
group of patients was 4 days (range, 3–8). 
DISCUSSION 
Laparoscopic pancreatic surgery has undergone significant development in the last decade. 
However, almost all of the procedures carried out are enucleations and distal pancreatectomies. It has 
been claimed that, aside from these procedures, laparoscopic approach does not seem to provide any 
benefit in more complex procedures.12
We have appreciated the importance of preserving pancreatic parenchyma and have performed 
open MP since 1999.13 Acquisition of skills in advanced laparoscopic surgery and laparoscopic distal 
pancreatectomies14 has allowed us to offer our patients the benefits of MP with the advantages of the 
laparoscopic approach. The present series is, to our knowledge, the longest published to date for LMP. 
Our results indicate that LMP is feasible and safe. 
The data from the main publications on MP, performed by open surgery, are shown in Table 3. 
This information includes 433 patients from a total of 20 series. Most of them are small and 
heterogeneous series, and only a few of them gather more than 15 patients.2,3,15–18 These facts and the 
possible different selection criteria of the patients make it difficult to compare our results with those in 
Table 3. Nevertheless, it seems that the laparoscopic approach can offer advantages over the open 
approach in MP. The average morbidity of all the open published series is 41.58%, whereas in the 
present work it is 33%. Our median hospital stay (5 days) is the shortest of all the reports. During 
follow-up, we have not observed recurrent disease, pancreatitis, or endocrine or exocrine failure, 
which matches the findings in the literature for open MP.1–3 Laparoscopic approach, then, could offer 
lesser perioperative morbidity, less blood loss, and shorter hospital stay with similar long term results. 
Recently a 6-case series for LMP has been published in which a PG is performed in all patients.7 PG is 
technically easier and faster, as just one anastomosis is needed, but at least in this experience, it also 
delays the oral feeding that was resumed in a median of 11 days.  
 
 
Probably, this fact, and the use of abdominal drainage until day 10 could have contributed to 
prolong the length of stay (18 days, range, 15–25) losing one of the main advantages of the 
laparoscopic approach, as is the short hospital stay. On the other hand, PJ anastomosis is preferable to 
PG for long-term outcomes of pancreatic exocrine function after whipple resection.19 Having on 
account that MP is indicated in patients with an expected long survival, we could consider that the best 
management for the distal pancreas is a PJ. 
The mean intervention time for our series was 435 minutes. This reflects the demands of a 
precise and meticulous procedure, especially in the dissection of the splenic vessels and the 
performance of the PJ. The presence of inflammatory reaction of the distal pancreas in 2 patients and 
the high rate of associated procedures prolonged even more the operative times. If we examine the 
last 2 patients without associated procedures (patients 6 and 7), the mean intervention time decreases 
to 372 minutes that is shorter, although still quite far from the reported times for open MP or LMP 
with PG (Table 3). Although a decrease of the operative times is expected with the experience, we 
cannot affirm to have observed it yet.  
It is evident that LMP is a complex technique that entails a learning curve. One technical evolution 
that deserves special consideration is the method of transecting the pan-creas. In the first 2 patients, the 
pancreas was sectioned exclusively with a 3.5-mm endostapler. Fistula of the cephalic stump developed 
in these patients, resulting in the need for supplementary procedures and prolonged hospital stays. After 
this experience, we decided to use staple-line reinforcement with absorbable polymer membrane. Two 
recent studies report the efficacy of this reinforcement by reducing significantly the fistula rate after 
distal pancreatectomy when compared with standard stapling alone.20,21 The results of these studies 
should be validated in a randomized controlled trial, but our experience in this series supports these 
preliminary results. Since we first used it, we have not observed any cephalic stump fistula: in the last 7 
patients, the fistula rate (whether stump or anastomosis) was 0% and perioperative morbidity 14%. The 
median hospital stay for this group, in which this technical aspect was modified, was 4 days (range, 3–
30). 
Laparoscopic execution of the pancreatico-jejunal anastomosis has always been a major challenge 
because of its technical complexity.12,22 In our series, there were no anastomotic fistulas even in soft 
pancreas with a nondilated duct. Several factors should be kept in mind for the successful laparoscopic 
execution of this anastomosis. The use of 3-chip optics is very helpful to achieve sufficient definition 
and image quality to identify a 2-mm Wirsung duct and suture safely with a 6/0-monofilament. We 
place a pediatric feeding tube for the duct-to-mucosa anastomosis. Although the use of stents to tutor 
the anastomosis has not demonstrated any clear benefits, it also is true that it does not result in major 
morbidity.23 In our experience, the tutor facilitates the anastomosis procedure by keeping the duct 
patent. Another factor that may have had a favorable effect was not leaving aspiration drains. Some 
relevant studies state that patients with drains are more likely to develop an intra-abdominal abscess, 
collection, or fistula after pancreatic surgery.24–26 The last but most important factor is that the surgical 
team should be experienced in both pancreatic and advanced laparoscopic surgery. At our center, the 
same team performs upper gastrointestinal laparoscopic surgery and hepatobiliary surgery. 
In conclusion, the present series suggests that the laparoscopic approach in pancreatic 
surgery should not be restricted to distal pancreatectomy and enucleation. LMP has the same 
benefits as open MP, with the additional advantages of the laparoscopic approach, and seems to 
decrease morbidity. Buttressing the staple line with absorbable material seems to be effective in 
preventing pancreatic fistula after distal pancreatectomy when compared with standard stapling 
alone; nevertheless, this as pect need to be confirmed by a randomized controlled trial. Duct-to-
mucosa pancreaticojejunostomy can be performed successfully by laparoscopy and without leaks in 
the hands of surgeons experienced in pancreatic and advanced laparoscopic surgery. 
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TABLE 1. Demographic and Clinical Characteristics of the 
Patients 
   
Patient Gender Symptoms Tests Preoperative Diagnosis Size (mm) Final 
1 F Abdominal pain US, MRI, EUS SCN 25 SCN 
2 F Incidental US, CT, EUS NET 13 NET 
3 F Incidental US, CT, EUS NET 11 NET 
4 F Back pain MRI, EUS MCN 22 MCN 
5 F Back pain US, CT, EUS IPMN 13 SCN 
6 F Incidental US, CT, EUS NET 9 NET 
7 F Incidental, TG US, CT, EUS MCN 30 SCN 
8 F Incidental, TG US, CT, EUS MCN 30 SCN 
9 M Incidental CT, octreoscan, EUS NET 10 NET 
 
US indicates ultrasonography; MRI, magnetic resonance imaging; EUS, endoultrasound (all cases 
with cytology); CT, computed tomography; SCN, serous cystic neoplasm; NET, neuroendocrine 
tumor; MCN, mucinous cystic neoplasm; IPMN, intraductal papillary mucinous neoplasm; TG, 
tumoral growth during follow-up. 
 
 
 
 
 
TABLE 2. Surgical and Hospital Data     
Surgical Operative Estimated Closure of Hospi
Patient Procedure Time Loss (mL) Head Stump Surgical Treatment Stay
1 LMP + LC 357 <50 Endostapler Pancreaticfistula(head) ERCP Transgastric 41
2 LAMP + LC 420 <50 Endostapler Bleeding Relaparotomy ERCP 23 
    Pancreaticfistula(head) Transgastric drainage 
3 LMP + LC 495 <100 Endostapler with — — 8 
4 LMP 509 <100 Endostapler with Abscess Transgastric drainage 30 
5 LMP+LC 458 <50 Endostapler with — — 5 
6 LMP 359 <50 Endostapler with — — 3 
7 LMP 386 <50 Endostapler with — — 4 
8 LMP + LC 435 <50 Endostapler with — — 4 
9 LMP + LPG 494 <100 Endostapler with 
SLR
— — 4 
LMP indicates laparoscopic middle pancreatectomy; LAMP, laparoscopic-assisted middle 
pancreatectomy; LC, laparoscopic cholecystectomy; LPG, laparoscopic partial gastrectomy; SLR, 
staple-line reinforcement. 
 
 
 
 
 
 
 
TABLE 3.Main Published Series of MP        
Author n Open/L
Mean 
Operativ
e Anastomo
Estimat
ed 
Blood
Pancreatic
Fistula Reoperati Morbid Mortal Hospital Stay 
Rotman et 1 Open — PJ — 14% 3% 29% 0 27.6 (mean)
(1993)27 (9–120) 
Ikeda et al 2
4
Open — PJ — 4% 0 13% 0 
(1995)15
Partensky et 
l
1 Open — PG — 0 10% 40% 0 
(1998)28
Warshaw et 1 Open — PJ 200 17% 0 25% 0 8 (median) 
(1998)29      9.6 (mean) (6–
Iacono et al 1
3
Open 250 PJ — 15% 0 23.1% 0 19 (mean) (10–
38)(1998)30
Sperti et al 1
0
Open 273 PJ 440 30% 0 40% 0 26 (mean) 
(2000)31      (11–48) 
Celis et al 5 Open 336 PJ 200 0 0 0 0 <10 (median) 
(2001)32
Molino et al 4 Open 230 PJ — 0 0 0 0 14 (median) 
(2001)33      (10–23) 
Sauvanet et 
l
5 Open — PJ (49%) — 30% 5.6% 41% 2% 
(2002)16   PG (47%)   
CPS (4%)
Sugiyama et 5 Open — PG — 0 0 20% 0 
(2004)34
Goldstein et 
l
1
2
Open 226 PG 700 0 0 25% 0 6.5 (median) 
(2004)35      (5–15) 
Efron et al 1
4
Open 229 PG 412 36% 14.2% 50% 0 11.1 (mean) 
(2004)36      (±6.3) 
Shibata et al 1
0
Open 331 PJ 359 30% 0 50% 0 37 (19–49) 
(2004)37      40 (mean) 
Iacono et al 2
0
Open — PJ — 25% 0 35% 0 
(2005)17
Roggin et al 1 Open — 9 PJ — 30% — 60% 0 
(2006)1   1 PG   
Muller et al 4 Open 304 PJ 564 7.5% 5% 27.5% 2.5% 11 (median) 
(2006)2      (6–62) 
Christein et 
l
8 Open 288 PJ 381 63% 25% >63 0 15 (mean) 
(2006)38
Johnson et 
l
8 Open 234 6 PG 321 0 0 37.5% 0 10.5 (mean) 
(2006)39   2 PJ   (9–13) 
Bassi et al 6
1
Open — — — 51% A–C 0 >51
%
0 
(2007)18    21% B–C   
Crippa et al 1 Open 248 ± 60 311 ± 44% 0 58% 0 13 ± 9.5 
(2007)3
SaCunha et 
l
6 Lap 225 PG 125 33% 0 33% 0 18 (median) 
(2007)7
Present 
i
9 Lap 435 PJ <100 22% 22% 33% 0 5 (median) 
PG indicates pancreaticogastrostomy; PJ, pancreaticojejunostomy; CPS, closure of pancreatic stump. 
 
 
 
 
 
 
 
 
 
 
FIGURE 1. Trocar placement. The specimen is removed through the umbilical incision. 
 
 
 
 
 
 
FIGURE 2. A–H, Steps of the surgical procedure as described in the text. A, a cotton 
tape around the pancreatic neck; B, transecting the pancreas with reinforced 
endostapler; C, releasing the distal pancreas from the splenic vessels; D, distal section of 
the specimen. E, suturing the jejunal serosa to the posterior capsule of the pancreas; F, 
opening a hole in the jejunal loop with the hook; G, tightening the first duct-to-mucosa 
stitch; H, final aspect of the surgical field. PV indicates portal vein; SV, splenic vein; DP, 
distal pancreas; CS, cephalic stump; T, tumor; SA, splenic artery; JL, jejunal loop; W, 
Wirsung duct; EM, everted mucosa. 
 
 
 
 
 
  
 
FIGURE 3. CT images of tumors located in the neck (A) and body (B). They belong 
respectively to patients 5 and 4. Tumors are indicated with T. 
 
